Nancy Sohler to Narcotic Antagonists
This is a "connection" page, showing publications Nancy Sohler has written about Narcotic Antagonists.
Connection Strength
1.509
-
Cunningham CO, Giovanniello A, Li X, Kunins HV, Roose RJ, Sohler NL. A comparison of buprenorphine induction strategies: patient-centered home-based inductions versus standard-of-care office-based inductions. J Subst Abuse Treat. 2011 Jun; 40(4):349-56.
Score: 0.340
-
Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, Sohler N. Buprenorphine treatment in an urban community health center: what to expect. Fam Med. 2008 Jul-Aug; 40(7):500-6.
Score: 0.283
-
Fox AD, Chamberlain A, Sohler NL, Frost T, Cunningham CO. Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants. J Subst Abuse Treat. 2015 Jan; 48(1):112-6.
Score: 0.108
-
Fox AD, Sohler NL, Starrels JL, Ning Y, Giovanniello A, Cunningham CO. Pain is not associated with worse office-based buprenorphine treatment outcomes. Subst Abus. 2012; 33(4):361-5.
Score: 0.090
-
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R. The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S76-82.
Score: 0.085
-
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D. Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr. 2011 Mar 01; 56 Suppl 1:S83-90.
Score: 0.085
-
Whitley SD, Sohler NL, Kunins HV, Giovanniello A, Li X, Sacajiu G, Cunningham CO. Factors associated with complicated buprenorphine inductions. J Subst Abuse Treat. 2010 Jul; 39(1):51-7.
Score: 0.081
-
Kunins HV, Sohler NL, Roose RJ, Cunningham CO. HIV provider endorsement of primary care buprenorphine treatment: a vignette study. Fam Med. 2009 Nov-Dec; 41(10):722-8.
Score: 0.078
-
Sohler NL, Li X, Kunins HV, Sacajiu G, Giovanniello A, Whitley S, Cunningham CO. Home- versus office-based buprenorphine inductions for opioid-dependent patients. J Subst Abuse Treat. 2010 Mar; 38(2):153-9.
Score: 0.077
-
Netherland J, Botsko M, Egan JE, Saxon AJ, Cunningham CO, Finkelstein R, Gourevitch MN, Renner JA, Sohler N, Sullivan LE, Weiss L, Fiellin DA. Factors affecting willingness to provide buprenorphine treatment. J Subst Abuse Treat. 2009 Apr; 36(3):244-51.
Score: 0.071
-
Roose RJ, Kunins HV, Sohler NL, Elam RT, Cunningham CO. Nurse practitioner and physician assistant interest in prescribing buprenorphine. J Subst Abuse Treat. 2008 Jun; 34(4):456-9.
Score: 0.066
-
Cunningham CO, Sohler NL, McCoy K, Kunins HV. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital. Fam Med. 2006 May; 38(5):336-40.
Score: 0.061
-
Fox AD, Sohler NL, Frost T, Lopez C, Cunningham CO. Development and evaluation of a community-based buprenorphine treatment intervention. Harm Reduct J. 2017 05 12; 14(1):23.
Score: 0.033
-
Fox AD, Shah PA, Sohler NL, Lopez CM, Starrels JL, Cunningham CO. I heard about it from a friend: assessing interest in buprenorphine treatment. Subst Abus. 2014; 35(1):74-9.
Score: 0.026
-
Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO. A buprenorphine education and training program for primary care residents: implementation and evaluation. Subst Abus. 2013; 34(3):242-7.
Score: 0.024